Dr.Agarwal's Health Care IPO Details

Bookbuilding IPO | ₹3,027 Cr | Listed at BSE, NSE | Wed, Jan 29, 2025 - Fri, Jan 31, 2025

Dr.Agarwal's Health Care IPO Logo

Dr.Agarwal's Health Care IPO is a book build issue of ₹3,027.26 crores. The issue is a combination of fresh issue of 0.75 crore shares aggregating to ₹300.00 crores and offer for sale of 6.78 crore shares aggregating to ₹2,727.26 crores.

Dr.Agarwal's Health Care IPO bidding started from Jan 29, 2025 and ended on Jan 31, 2025. The allotment for Dr.Agarwal's Health Care IPO was finalized on Feb 3, 2025. The shares got listed on BSE, NSE on Feb 4, 2025.

Dr.Agarwal's Health Care IPO price band is set at ₹402 per share. The lot size for an application is 35. The minimum amount of investment required by an retail is ₹14,070 (35 shares) (based on upper price). The lot size investment for sNII is 15 lots (525 shares), amounting to ₹2,11,050, and for bNII, it is 72 lots (2,520 shares), amounting to ₹10,13,040.

The issue includes a reservation of up to 15,79,399 shares for employees offered at a discount of ₹0.00 to the issue price.

Kotak Mahindra Capital Co.Ltd. is the book running lead manager and Kfin Technologies Ltd. is the registrar of the issue.

Refer to Dr.Agarwal's Health Care IPO RHP for detailed Information.

IPO Open

Wed, Jan 29, 2025

IPO Close

Fri, Jan 31, 2025

Issue Price

₹402 per share

Market Cap (Pre-IPO)

₹12,698.37 Cr

IPO Details

IPO Date29 to 31 Jan, 2025
Listed onTue, Feb 4, 2025
Face Value1 per share
Price Band₹382 to ₹402
Issue Price₹402 per share
Lot Size35 Shares
Sale TypeFresh capital cum OFS
Issue TypeBookbuilding IPO
Listing AtBSE, NSE

Total Issue Size7,53,04,970 shares
(agg. up to ₹3,027 Cr)
Fresh Issue 74,62,686 shares
(agg. up to ₹300 Cr)
Offer for Sale6,78,42,284 shares of ₹1
(agg. up to ₹2,727 Cr)
Share Holding Pre Issue30,84,17,160 shares
Share Holding Post Issue31,58,79,846 shares
BSE Script Code / NSE Symbol544350 / AGARWALEYE
ISININE943P01029

IPO Timetable

IPO Reservation

Dr.Agarwal's Health Care IPO offers total 7,53,04,970 shares. Out of which 3,62,97,998 (48.20%) allocated to QIB, 1,45,19,200 (19.28%) allocated to QIB (Ex- Anchor), 1,08,89,400 (14.46%) allocated to NII 2,54,08,599 (33.74%) allocated to RII and 2,17,78,798 (28.92%) allocated to Anchor investors.

Investor Category Shares Offered Max Allottees
QIB Shares Offered 3,62,97,998 (48.20%)NA
  − Anchor Investor Shares Offered 2,17,78,798 (28.92%)NA
  − QIB (Ex. Anchor) Shares Offered 1,45,19,200 (19.28%)NA
NII (HNI) Shares Offered 1,08,89,400 (14.46%)NA
  − bNII > ₹10L 72,59,600 (9.64%)13,827
  − sNII < ₹10L 36,29,800 (4.82%)6,913
Retail Shares Offered 2,54,08,599 (33.74%)7,25,959
Employee Shares Offered 15,79,399 (2.10%)NA
Shareholders Shares Offered 11,29,574 (1.50%)NA
Total Shares Offered7,53,04,970 (100.00%)

IPO Lot Size

Investors can bid for a minimum of 35 shares and in multiples thereof. 

Application Lots Shares Amount
Retail (Min) 1 35 ₹14,070
Retail (Max) 14 490 ₹1,96,980
S-HNI (Min) 15 525 ₹2,11,050
S-HNI (Max) 71 2,485 ₹9,98,970
B-HNI (Min) 72 2,520 ₹10,13,040
IPO Subscription Details

IPO Anchor Investors

Dr.Agarwal's Health Care IPO raises ₹875.51 crore from anchor investors. Dr.Agarwal's Health Care IPO Anchor bid date is January 28, 2025.
📝 Anchor Investors Letter (PDF)

Bid DateTue, Jan 28, 2025
Shares Offered2,17,78,798
Anchor Portion (₹ Cr.)875.51
Anchor lock-in period end date for 50% shares (30 Days)Sun, Mar 2, 2025
Anchor lock-in period end date for remaining shares (90 Days)Thu, May 1, 2025

Investor Category Reservations

Application CategoryMaximum Bidding LimitsBidding at Cut-off Price Allowed
Only RII Up to Rs 2 Lakhs Yes
Only sNII Rs 2 Lakhs to Rs 10 Lakhs No
Only bNII Rs 10 Lakhs to NII Reservation Portion No
Only shareholder Up to Rs 2 Lakhs Allowed only if bidding amount is upto Rs 2 lakhs
Only employee Up to Rs 5 Lakhs Yes
Employee + Shareholder
  1. Shareholder limit: Up to Rs 2 Lakhs
  2. Employee limit: Up to Rs 5 Lakhs. (In certain cases, employees are given discount if bidding amount is upto Rs. 2 lakhs)
Yes
Employee + Shareholder + RII/NII
  1. Shareholder limit: Up to Rs 2 Lakhs
  2. Employee limit: Up to Rs 5 Lakhs (In certain cases, employees are given discount if bidding amount is upto Rs. 2 lakhs)
  3. If applying as RII: Upto Rs. 2 lakhs
  4. If applying as NII: sNII > Rs. 2 lakhs and upto Rs. 10 lakhs and bNII > Rs. 10 lakhs
Yes for shareholder/employee/RII
Shareholder + RII/NII
  • Shareholder limit: Upto Rs. 2 lakhs
  • If applying as RII: Upto Rs. 2 lakhs
  • If applying as NII: sNII > Rs. 2 lakhs and upto Rs. 10 lakhs and bNII > Rs. 10 lakhs
Yes for shareholder/RII
Employee + RII/NII
  • Employee limit: Up to Rs 5 Lakhs (In certain cases, employees are given discount if bidding amount is upto Rs. 2 lakhs)
  • If applying as RII: Upto Rs. 2 lakhs
  • If applying as NII: sNII > Rs. 2 lakhs and upto Rs. 10 lakhs and bNII > Rs. 10 lakhs
Yes for shareholder/RII

Note: To be eligible for the Shareholder Quota, you must hold shares in one of the following companies:

  • Dr Agarwals Eye Hospital Ltd

About Dr.Agarwal's Health Care Ltd.

Incorporated in 2010, Dr. Agarwal's Health Care Limited offers a comprehensive range of eye care services, including cataract and refractive surgeries, consultations, diagnoses, non-surgical treatments, and the sale of optical products, contact lenses, accessories, and eye care-related pharmaceutical items.

As of September 30, 2024, there were 737 doctors providing care to patients across the company's facilities. During this period, the company served 2.13 million patients and performed 220,523 surgeries. In the six months leading up to September 30, 2024, they served 1.15 million patients and conducted 140,787 surgeries.

The Services provided by the company are:-

Cataract surgeries Offer cataract surgical treatments at its Facilities, such as small incision cataract surgery, phacoemulsification, robotic cataract surgery and glued intraocular lens treatments;

Refractive surgeries: Refractive surgeries are procedures that correct eye refractive errors, helping individuals reduce or eliminate their need for glasses and contact lenses. The main types include LASIK, SMILE, implantable collamer lenses, and photorefractive keratectomy (PRK).

Other surgeries: Offer a range of other surgical treatments for eye ailments, such as surgical retinal treatments, corneal transplantation and pinhole pupilloplasty, oculoplasty and surgeries for the treatment of glaucoma and pterygium.

As of September 30, 2024, the company's Indian network has 28 hubs (Tertiary Facilities, including three COEs) and 165 spokes (53 Primary and 112 Secondary Facilities).

As of September 30, 2024, the company has a presence in India across 117 metro and non-metro cities spanning 14 states and four union territories through 193 Facilities.

Competitive Strength

  • Largest eye care services provider in India with a trusted brand
  • End-to-end, comprehensive eye care services offering
  • Scalable, asset-light, hub-and-spoke operating model
  • Proven clinical excellence is driven by a strong clinical board and a history of surgical innovations. 
  • Doctor-promoters leading a team of qualified medical professionals and supported by experienced management
  • Proven track record of delivering organic growth, integrating and scaling acquisitions and improving operating profitability

Company Financials (Restated Consolidated)

Period Ended30 Sep 202431 Mar 202431 Mar 202331 Mar 2022
Assets3,393.412,752.821,825.171,026.13
Total Income837.941,376.451,031.49713.78
Profit After Tax39.5695.05103.2343.16
NET Worth1,502.671,337.68627.83212.34
Reserves and Surplus1,509.111,365.86652.63236.27
Total Borrowing373.68387.79356.18290.18
Amount in ₹ Crore

IPO Objects of the Issue

The Company proposes to utilise the Net Proceeds from the Issue towards the following objects:

# Issue Objects Est Amt (₹ Cr.)
1 Repayment/prepayment, in part or full, of certain of the borrowings 195.00
2 General corporate purposes and unidentified inorganic acquisition 77.47

Key Performance Indicator (KPI)

Pre IPOPost IPO
EPS (₹)3.082.51
P/E (x)130.44160.48
Promoter Holding37.72%32.5%
Market Cap12,698.37 Cr.
The Promoters of the Company are Dr. Amar Agarwal, Dr. Athiya Agarwal, Dr Adil Agarwal, Dr. Anosh Agarwal, Dr Ashvin Agarwal, Dr. Ashar Agarwal, Dr. Amar Agarwal Family Trust, Dr Adil Agarwal Family Trust, Dr. Anosh Agarwal Family Trust, Dr Ashvin Agarwal Family Trust, Dr. Ashar Agarwal Family Trust, Dr Agarwal’s Eye Institute and Dr Agarwal's Eye Institute Private Limited
  • The value will be calculated using Equity Dilution = Share Holding Pre Issue - Share Holding Post Issue
  • The Pre IPO EPS is calculated based on Pre issue shareholding as on date of RHP and the latest FY earnings as of March 31, 2024 available in RHP.
  • The Post Issue EPS is calculated based on the Post issue shareholding and annualized FY earnings of September 30, 2024 available in RHP.

IPO Review

[Dilip Davda]
The company is engaged in eye care business providing all eye health related treatments. While its top line marked steady growth for the reported periods, it posted pressure on margins for FY23. It has nearly 25% market share in its business of eye-care related services. Based on recent financial performance, the issue appears exorbitantly priced. Only well-informed/cash surplus/risk seekers may park moderate funds for long term considering future prospects.
Read detail review...

Dr.Agarwal's Health Care IPO Recommendations

Review BySubscribeMay ApplyNeutralAvoid
Brokers1521
Members2006

Dr Agarwals Healthcare IPO Subscription Status (Bidding Detail)

The Dr Agarwals Healthcare IPO is subscribed 1.49 times on January 31, 2025 5:04:51 PM (Day 3). The public issue subscribed 0.42 times in the retail category, 4.41 times in the QIB category, and 0.39 times in the NII category. Check Day by Day Subscription Details (Live Status)

CategorySubscription (times)Shares OfferedShares bid for
QIB4.411,45,19,2006,40,02,575
NII0.391,08,89,40042,75,705
    bNII (bids above ₹10L)0.2972,59,60021,19,880
    sNII (bids below ₹10L)0.5436,29,80019,54,820
Retail0.422,54,08,5991,05,59,535
Employee0.2615,79,3994,18,110
Others0.5111,29,5745,74,210
Total1.495,35,26,1727,98,30,135

Total Application : 2,53,169

IPO Expenses

# Issue Expenses Est Amt (₹ Cr.)
1 BRLMs fees and commissions (including underwriting commission, brokerage and selling commission) 84.32
2 Commission/ processing fee for SCSBs and Bankers to the Offer and fees payable to the Sponsor Bank(s) for Bids made by UPI Bidders. Brokerage, selling commission and bidding charges for Members of the Syndicate, Registered Brokers, RTAs and CDPs 5.46
3 Fees payable to the Registrar to the Offer
4 Auditors 5.14
5 Independent Chartered Accountant 1.55
6 Industry expert 0.68
7 Fee payable to legal counsel 10.15
8 Others 1.59
9 Listing fees, SEBI filing fees, upload fees, BSE and NSE processing fees, book building software fees and other regulatory expenses 14.66
10 Printing and stationery 3.81
11 Advertising and marketing expenses 12.16
12 Miscellaneous 1.16

Listing Day Trading Information

Price DetailsBSENSE
Final Issue Price402.00402.00
Open396.90402.00
Low370.10370.20
High412.75412.90
Last Trade401.55401.65

Check IPO Performance…

IPO Registrar

Kfin Technologies Ltd.

Contact Details

Dr.Agarwal's Health Care Ltd. Address
1 st Floor, Buhari Towers
No.4, Moores Road, Off Greams Road,
Near Asan Memorial School, Chennai 600 006
Chennai, Tamil Nadu
Open an Instant Account with Zerodha

IPO FAQs

Dr.Agarwal's Health Care IPO is a main-board IPO of 7,53,04,970 equity shares of the face value of ₹1 aggregating up to ₹3,027 Crores. The issue is priced at ₹402 per share. The minimum order quantity is 35.

The IPO opens on Wed, Jan 29, 2025, and closes on Fri, Jan 31, 2025.

Kfin Technologies Ltd. is the registrar for the IPO. The shares are proposed to be listed on BSE, NSE.

Zerodha customers can apply online in Dr.Agarwal's Health Care IPO using UPI as a payment gateway. Zerodha customers can apply in Dr.Agarwal's Health Care IPO by login into Zerodha Console (back office) and submitting an IPO application form.

Steps to apply in Dr.Agarwal's Health Care IPO through Zerodha

  1. Visit the Zerodha website and login to Console.
  2. Go to Portfolio and click the IPOs link.
  3. Go to the 'Dr.Agarwal's Health Care IPO' row and click the 'Bid' button.
  4. Enter your UPI ID, Quantity, and Price.
  5. Submit IPO application form.
  6. Visit the UPI App (net banking or BHIM) to approve the mandate.

Visit Zerodha IPO Application Process Review for more detail.

The Dr.Agarwal's Health Care IPO opens on Wed, Jan 29, 2025 and closes on Fri, Jan 31, 2025.

Dr.Agarwal's Health Care IPO lot size is 35, and the minimum amount required for application is ₹14,070.

You can apply in Dr.Agarwal's Health Care IPO online using either UPI or ASBA as a payment method. ASBA IPO application is available in the net banking of your bank account. UPI IPO Application is offered by brokers who don't offer banking services. Read more detail about applying IPO online through Zerodha, Upstox, 5Paisa, Nuvama, HDFC Bank, and SBI Bank.

The finalization of Basis of Allotment for Dr.Agarwal's Health Care IPO will be done on Monday, February 3, 2025, and the allotted shares will be credited to your demat account by Tue, Feb 4, 2025. Check the Dr.Agarwal's Health Care IPO allotment status.

The Dr.Agarwal's Health Care IPO listing date is on Tue, Feb 4, 2025.

Compare: